tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Adam Walsh, 83 are a BUY (87.37%), 11 are a HOLD (11.58%), 1 are a SELL (1.05%).
Analyst Adam Walsh, currently employed at ROTH, carries an average stock price target met ratio of 55.76% that have a potential upside of 41.61% achieved within 268 days. Previously, Adam Walsh worked at ROTH MKM.
Adam Walsh’s has documented 184 price targets and ratings displayed on 20 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on INSM, Insmed at 15-Sep-2026.
Analyst best performing recommendations are on EQ (EQUILLIUM).
The best stock recommendation documented was for EQ (EQUILLIUM) at 7/10/2020. The price target of $10 was fulfilled within 3 days with a profit of $6.81 (213.48%) receiving and performance score of 711.6.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$17
3 years 8 months 18 days ago
(20-Jan-2023)
0/1 (0%)
$10.12 (147.09%)
Buy
$25
3 years 8 months 19 days ago
(19-Jan-2023)
0/6 (0%)
$18.01 (257.65%)
Hold Since 19-Jan-2023
$25
3 years 8 months 19 days ago
(19-Jan-2023)
0/6 (0%)
$18.01 (257.65%)
Buy Since 04-Nov-2020
$10
3 years 8 months 19 days ago
(19-Jan-2023)
0/3 (0%)
$6 (150.00%)
Buy Since 24-Jul-2017
$17
$8.63 (103.11%)
$17
4 years 4 months 15 days ago
(23-May-2022)
1/7 (14.29%)
$12.9 (314.63%)
115
Which stock is Adam Walsh most bullish on?
Which stock is Adam Walsh most reserved on?
What Year was the first public recommendation made by Adam Walsh?
